A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma

The optimal combined chemotherapy regimen with rituximab has yet to be established for elderly patients with advanced-stage indolent B-cell lymphoma (B-NHL). A multicenter study was performed to evaluate the efficacy and toxicity of R-THP-COP therapy in elderly patients (aged 70–79 years) with newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Kazunori, Ohmachi, Ken, Ando, Kiyoshi, Yamamoto, Kazuhito, Ito, Tatsuya, Tanimoto, Mitsune, Ohbayashi, Kaneyuki, Ohyashiki, Kazuma, Tsukasaki, Kunihiro, Naito, Kensuke, Suzuki, Takayo, Ono, Takaaki, Miyamura, Koichi, Kagami, Yoshitoyo, Kinoshita, Tomohiro, Hotta, Tomomitsu, Ogura, Michinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519245/
https://www.ncbi.nlm.nih.gov/pubmed/34193755
http://dx.doi.org/10.3960/jslrt.21004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519245/
https://www.ncbi.nlm.nih.gov/pubmed/34193755
http://dx.doi.org/10.3960/jslrt.21004

Ejemplares similares